Search Results - Benjamin M. Pullinger

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia Infections by Mohammed Al Musawa, Ashlan J. Kunz Coyne, Sara Alosaimy, Kristen Lucas, Melanie Rae Schrack, Justin Andrade, Shelbye R. Herbin, Mark Biagi, Michael Pierce, Kyle C. Molina, Alaina DeKerlegand, Nicholson B. Perkins, Reese Cosimi, Lena Kang-Birken, Madeline A. King, Benjamin M. Pullinger, Leonor M. Rojas, Jeannette Bouchard, Athena L. V. Hobbs, Jazmin Agee, Kaylee E. Caniff, Sean R. Van Helden, Michael P. Veve, Michael J. Rybak

    Published in Infectious Diseases and Therapy (2025-06-01)
    Get full text
    Article


  2. 2

    Correction: Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia Infections by Mohammed Al Musawa, Ashlan J. Kunz Coyne, Sara Alosaimy, Kristen Lucas, Melanie Rae Schrack, Justin Andrade, Shelbye R. Herbin, Mark Biagi, Michael Pierce, Kyle C. Molina, Alaina DeKerlegand, Nicholson B. Perkins, Reese Cosimi, Lena Kang-Birken, Madeline A. King, Benjamin M. Pullinger, Leonor M. Rojas, Jeannette Bouchard, Athena L. V. Hobbs, Jazmin Agee, Kaylee E. Caniff, Sean R. Van Helden, Michael P. Veve, Michael J. Rybak

    Published in Infectious Diseases and Therapy (2025-09-01)
    Get full text
    Article


  3. 3

    Eravacycline use in immunocompromised patients: multicenter evaluation of timely versus late initiation on clinical outcomes by Ashlan J. Kunz Coyne, Sara Alosaimy, Kristen Lucas, Taylor Morrisette, Kyle C. Molina, Alaina DeKerlegand, Melanie Rae Schrack, S. Lena Kang-Birken, Athena L. V. Hobbs, Jazmin Agee, Nicholson B. Perkins, Mark Biagi, Michael Pierce, James Truong, Justin Andrade, Jeannette Bouchard, Tristan Gore, Madeline A. King, Benjamin M. Pullinger, Kimberly C. Claeys, Shelbye Herbin, Reese Cosimi, Serina Tart, Michael P. Veve, Bruce M. Jones, Leonor M. Rojas, Amy K. Feehan, Jing J. Zhao, Paige Witucki, Michael J. Rybak

    Published in Microbiology Spectrum (2025-10-01)
    Get full text
    Article


  4. 4

    Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022 by Ashlan J. Kunz Coyne, Sara Alosaimy, Kristen Lucas, Abdalhamid M. Lagnf, Taylor Morrisette, Kyle C. Molina, Alaina DeKerlegand, Melanie Rae Schrack, S. Lena Kang-Birken, Athena L.V. Hobbs, Jazmin Agee, Nicholson B. Perkins, Mark Biagi, Michael Pierce, James Truong, Justin Andrade, Jeannette Bouchard, Tristan Gore, Madeline A. King, Benjamin M. Pullinger, Kimberly C. Claeys, Shelbye Herbin, Reese Cosimi, Serina Tart, Michael P. Veve, Bruce M. Jones, Leonor M. Rojas, Amy K. Feehan, Marco R. Scipione, Jing J. Zhao, Paige Witucki, Michael J. Rybak

    Published in Microbiology Spectrum (2024-01-01)
    Get full text
    Article


Search Tools: